RITUXIMAB SIGNIFICANTLY DIMINISHES CD86+B CELLS IN SYSTEMIC SCLEROSIS

Barbara Dreo; Barbara Prietl; Selina Kofler; Harald Sourij; Angelika Lackner; F Furst-Moazedi; M D'Orazio; Martin Helmut Stradner; Winfried Graninger; Hans-Peter Brezinsek

doi:10.1136/annrheumdis-2019-eular.8047

RITUXIMAB SIGNIFICANTLY DIMINISHES CD86+B CELLS IN SYSTEMIC SCLEROSIS

Barbara Dreo
, Barbara Prietl
, Selina Kofler
, Harald Sourij
, Angelika Lackner
, F Furst-Moazedi
, M D'Orazio
, Martin Helmut Stradner
, Winfried Graninger
, Hans-Peter Brezinsek

Research output: Contribution to journal › Conference abstract

Original language	English
Journal	Annals of the Rheumatic Diseases
DOIs	https://doi.org/10.1136/annrheumdis-2019-eular.8047
Publication status	Published - 2019
Event	20th Annual European Congress of Rheumatology - Madrid, Spain Duration: 12 Jun 2019 → 15 Jun 2019

Branches of science

106 Biology
302 Clinical Medicine
305 Other Human Medicine, Health Sciences
303 Health Sciences

DOI

10.1136/annrheumdis-2019-eular.8047

Links

Web of Science

RITUXIMAB SIGNIFICANTLY DIMINISHES CD86+B CELLS IN SYSTEMIC SCLEROSIS
Dreo, B. (Author), Prietl, B. (Author), Kofler, S. (Author), Sourij, H. (Author), Lackner, A. (Author), Furst-Moazedi, F. (Author), D'Orazio, M. (Author), Stradner, M. H. (Author), Graninger, W. (Author) & Brezinsek, H.-P. (Author)
2019
Activity: Talk, presentation or poster › Poster

Cite this

@article{7d6d0e7085bf4dae8849d51a5aff02c8,

title = "RITUXIMAB SIGNIFICANTLY DIMINISHES CD86+B CELLS IN SYSTEMIC SCLEROSIS",

author = "Barbara Dreo and Barbara Prietl and Selina Kofler and Harald Sourij and Angelika Lackner and F Furst-Moazedi and M D'Orazio and Stradner, \{Martin Helmut\} and Winfried Graninger and Hans-Peter Brezinsek",

year = "2019",

doi = "10.1136/annrheumdis-2019-eular.8047",

language = "English",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier B.V.",

note = "20th Annual European Congress of Rheumatology, EULAR 20 ; Conference date: 12-06-2019 Through 15-06-2019",

}

TY - JOUR

T1 - RITUXIMAB SIGNIFICANTLY DIMINISHES CD86+B CELLS IN SYSTEMIC SCLEROSIS

AU - Dreo, Barbara

AU - Prietl, Barbara

AU - Kofler, Selina

AU - Sourij, Harald

AU - Lackner, Angelika

AU - Furst-Moazedi, F

AU - D'Orazio, M

AU - Stradner, Martin Helmut

AU - Graninger, Winfried

AU - Brezinsek, Hans-Peter

PY - 2019

Y1 - 2019

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000472207103458

U2 - 10.1136/annrheumdis-2019-eular.8047

DO - 10.1136/annrheumdis-2019-eular.8047

M3 - Conference abstract

SN - 0003-4967

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

T2 - 20th Annual European Congress of Rheumatology

Y2 - 12 June 2019 through 15 June 2019

ER -

RITUXIMAB SIGNIFICANTLY DIMINISHES CD86+B CELLS IN SYSTEMIC SCLEROSIS

Branches of science

DOI

Links

Activities

RITUXIMAB SIGNIFICANTLY DIMINISHES CD86+B CELLS IN SYSTEMIC SCLEROSIS

Cite this